Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future
Industry insiders weigh in on the growing pains of Oregon's regulated psilocybin program which has seen concerns raised about licensing fees and some service centers close. The post Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future first appeared on Lucid News. The post Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future appeared first on Lucid News.
External link. We are not responsible for the content.
Read more ↗More From Lucid News
Psychedelic Policy Briefing 8.21.26
Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New ...
Weekly Psychedelic Policy Briefing – August 14, 2026
The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research o...
Psychedelic Policy Briefing
In this week's psychedelic policy briefing, investigative journalist Jack Gorsline unpacks a wave of state and federa...
Latest News
A federal report encourages states to prepare for FDA approval of psychedelics; Could THC help with the psychedelic blinding problem?
Plus: Ketamine seized at the UK border hits record high; an Arizona ibogaine trial; Study reveals cell signaling that...
7 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. An independent media platform covering drugs, altered states & the culture surroundi...
Is “Gas Station Molly” the Next Big Grey Market Drug?
It feels like MDMA, skips the comedown, and it's already on head shop shelves. But is it legal? [...] Read More... Th...
Scent, Ritual, and Altered States
Kamila Aubre explores scent and the psychedelic experience
Inside the First Ayahuasca Forum Hosted by Indigenous Peoples
100 Indigenous leaders will gather at the World Ayahuasca Forum to set the terms for ayahuasca's future. [...] Read M...
Can Psilocybin Protect Skin Cells From Premature Aging?
PLUS Carlos Castaneda, foraging for psilocybin mushrooms, and Resilient Pharmaceuticals. [...] Read More... The post ...